中华病理学杂志最新文献

筛选
英文 中文
[Advances in haematolymphoid pathology in China over the past ten years: retrospect and prospect]. 【近十年来中国血淋巴病理研究进展:回顾与展望】。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20241010-00665
Z H Zhang, L C Guo, W Y Zhang, Z Wang
{"title":"[Advances in haematolymphoid pathology in China over the past ten years: retrospect and prospect].","authors":"Z H Zhang, L C Guo, W Y Zhang, Z Wang","doi":"10.3760/cma.j.cn112151-20241010-00665","DOIUrl":"10.3760/cma.j.cn112151-20241010-00665","url":null,"abstract":"<p><p>In the past decade, significant progress has been made in the field of haematolymphoid pathology in China. Domestic experts have published nearly 100 articles in the <i>Chinese Journal of Pathology</i> and international authoritative journals. These achievements have deepened the fundamental theoretical research of haematolymphoid pathology and significantly improved the clinical pathological diagnosis level, providing valuable Chinese data for the pathological diagnosis and research of haematolymphoid diseases internationally. In addition, the domestic haematolymphoid pathological diagnosis and training system has been comprehensively optimized, with closer interaction and integration with clinical medicine, cultivating a large number of specialized pathologists, and driving innovation and development of the entire pathology discipline.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"334-341"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress of different components of tertiary lymphoid structure on tumor immunity]. [三级淋巴结构不同组分对肿瘤免疫的研究进展]。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20241011-00670
Z Y Chen, P Z Ji, Q Q He, G W Gao, H T Zhu, Y L Yang
{"title":"[Research progress of different components of tertiary lymphoid structure on tumor immunity].","authors":"Z Y Chen, P Z Ji, Q Q He, G W Gao, H T Zhu, Y L Yang","doi":"10.3760/cma.j.cn112151-20241011-00670","DOIUrl":"10.3760/cma.j.cn112151-20241011-00670","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"419-424"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vascular malformation in head and neck: a clinicopathological analysis of 675 cases]. 头颈部血管畸形675例临床病理分析
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20240716-00459
H R Chen, C X Li, D K Liu, Q Y Liu
{"title":"[Vascular malformation in head and neck: a clinicopathological analysis of 675 cases].","authors":"H R Chen, C X Li, D K Liu, Q Y Liu","doi":"10.3760/cma.j.cn112151-20240716-00459","DOIUrl":"10.3760/cma.j.cn112151-20240716-00459","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the histopathological subtype and clinical characteristics of vascular malformations in the head and neck. <b>Methods:</b> All patients with head and neck vascular malformations referred to Henan Provincial People's Hospital between January 2021 and December 2023 were collected, and the clinicopathological features were analyzed by SPSS 26.0 statistical software. <b>Results:</b> A total of 675 patients were included, there were 293 male and 382 female patients with a mean onset age of (26.2±21.8)years and a mean diagnosis age of (31.8±20.6)years. Most vascular malformations were located in oral and maxillofacial region (52.1%, 352/675), with an average diameter of (28.0±19.8)mm. Venous malformations were the most common (71.4%, 482/675). There were 230 patients presented with simultaneous phenomenon, and of them the thrombus was most commonly noted (66.5%, 153/230). Venous malformations more frequently occurred in patients who were older than 20 years, extracranial in site, and mostly involved female patients with complications. Combined vascular malformation more frequently occurred in patients who were under 20 years old, extracranial in site, and mostly involved female patients. Capillary malformations more frequently occurred in patients under 20 years old, extracranial in site, and no complications occurred. Lymphatic vessel malformation more frequently occurred in patients who were under 20 years old, extracranial in site, female and with no complications. Arteriovenous malformations were more common in the intracranial and most of them were without any complications. Two cases (2/21) were associated with PIK3CA gene mutation. There were 109 patients with recurrence after initial treatment. <b>Conclusions:</b> Vascular malformations in the head and neck are more commonly found in the extracranial and maxillofacial regions, and venous malformations are the most common type; while arteriovenous malformations are more common in the intracranial site. Appropriate diagnosis is the premise of appropriate treatment.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"387-393"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Klippel-Trenaunay syndrome: report of a case]. Klippel-Trenaunay综合征1例报告。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20241126-00787
Y Feng, S S Cheng, M Li, M H Zheng, Y Wang, Q Y Liu
{"title":"[Klippel-Trenaunay syndrome: report of a case].","authors":"Y Feng, S S Cheng, M Li, M H Zheng, Y Wang, Q Y Liu","doi":"10.3760/cma.j.cn112151-20241126-00787","DOIUrl":"10.3760/cma.j.cn112151-20241126-00787","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"412-414"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Correlation between p53 immunohistochemistry and TP53 mutations in gliomas]. [胶质瘤中p53免疫组化与TP53突变的相关性]。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20241010-00666
X F Lin, C C Hu, P L Wang, X L Su, J J Wu, S F Zeng, S Zhang, X F Wang
{"title":"[Correlation between p53 immunohistochemistry and TP53 mutations in gliomas].","authors":"X F Lin, C C Hu, P L Wang, X L Su, J J Wu, S F Zeng, S Zhang, X F Wang","doi":"10.3760/cma.j.cn112151-20241010-00666","DOIUrl":"10.3760/cma.j.cn112151-20241010-00666","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the accuracy of p53 immunohistochemistry for predicting the mutational status of TP53 in gliomas. <b>Methods:</b> A retrospective study was conducted on 242 diffuse gliomas diagnosed at the Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China from June 2022 to March 2023. All cases underwent next-generation sequencing (NGS) and p53 immunohistochemical staining. The best threshold in the percentage of p53 immunohistochemical expression was assessed as an alternative to testing for TP53 mutation. <b>Results:</b> Among the 242 diffuse gliomas (WHO grade 2-4), 94 cases had a TP53 mutation. The p53 immunohistochemistry results revealed a significantly increased probability of TP53 mutation when the p53 immunohistochemical positivity rate (based on strongly positive cell count) was ≥20% (<i>P</i><0.05). The sensitivity and specificity of p53 immunohistochemistry for predicting TP53 gene mutations were 75.6% and 90.4%, respectively. When p53 immunohistochemical stain was totally negative, the probability of TP53 mutation increased significantly, and the mutation ratio of TP53 gene was 6/17 in all negative cases. <b>Conclusions:</b> When the percentage of p53 positive cells (based on strongly positive cell count) in glioma is ≥20%, p53 immunohistochemistry can be used as a reliable alternative method for TP53 mutation detection. When p53 immunohistochemistry is completely negative, the mutation rate of TP53 gene is higher, and further gene sequencing is recommended to determine the mutation status.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"375-380"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PRRX1-rearranged fibroblastic tumor: a clinicopathological and molecular analysis of four cases]. prrx1重排纤维母细胞瘤:4例临床病理及分子分析
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20250124-00063
R F Xu, P P Zhu, J Wang
{"title":"[PRRX1-rearranged fibroblastic tumor: a clinicopathological and molecular analysis of four cases].","authors":"R F Xu, P P Zhu, J Wang","doi":"10.3760/cma.j.cn112151-20250124-00063","DOIUrl":"10.3760/cma.j.cn112151-20250124-00063","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinicopathological features, immunophenotypes, and molecular characteristics of PRRX1-rearranged fibroblastic tumor and to discuss their differential diagnoses. <b>Methods:</b> Four cases of PRRX1-rearranged fibroblastic tumor retrieved from Anning First People's Hospital and Fudan University Shanghai Cancer Center and their clinicopathological features, immunophenotypes and molecular profiles were analyzed. The literature was reviewed. <b>Results:</b> All 4 cases occurred in adult women with an age of 34(27,41) years. Three tumors occurred in the low extremities and 1 in the trunk. The patients presented with a slowly growing mass or swelling, accompanied by pain in 1 patient. Three tumors were located in the subcutis, and 1 tumor in the intermuscular space. The duration lasted for 6 months to 1 year. Tumor ranged in size from 4.0 to 15.8 cm (mean 7.3 cm). At lower power, the tumors were well circumscribed, showing a multinodular architecture. They were composed of bland ovoid to short spindled cells arranged irregularly with interstitial ropey collagen fibers, and set in a fibrous to fibromyxoid matrix with a close resemblance to low-grade fibromyxoid sarcoma. However, all 4 tumors showed negative staining for MUC4. Two tumors were focally positive for S-100 and SOX10. Apart from vimentin, they were all negative for other immunohistochemical stains including SMA, desmin, CD34, STAT6 and β-catenin. The expression of H3K27Me3 was retained. The proliferative index measured by Ki-67 was less than 5%. RNA-sequencing analysis identified PRRX1::NCOA1 fusions in 3 cases, and PRRX1::KMT2D fusion in 1 case. Subsequent FISH study confirmed NCOA1 rearrangement in 3 cases harboring NCOA1 rearrangement. On follow-up (1-14 months), no patient developed either local recurrence or distant metastasis. <b>Conclusions:</b> PRRX1-rearranged fibroblastic tumor is a novel entity of soft tissue tumor that has a predilection for the trunk and extremities, characterized by PRRX1 gene rearrangement and benign clinical course. Familiarity with its clinicopathological features is helpful in the distinction from low-grade fibromyxoid sarcoma and other spindle cell tumors with overlapping features.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"381-386"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Immunodeficiency and dysregulation-related peripheral T cell lymphoma, not otherwise specified, combined with Langerhans cell histiocytosis: report of a case]. [免疫缺陷和失调相关的外周T细胞淋巴瘤,未另行说明,合并朗格汉斯细胞组织细胞增多症:1例报告]。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20241025-00699
T Chen, X W Ge
{"title":"[Immunodeficiency and dysregulation-related peripheral T cell lymphoma, not otherwise specified, combined with Langerhans cell histiocytosis: report of a case].","authors":"T Chen, X W Ge","doi":"10.3760/cma.j.cn112151-20241025-00699","DOIUrl":"10.3760/cma.j.cn112151-20241025-00699","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"403-405"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Long-term disease-free survival hepatic cavernous hemangioma with intravascular large B cell lymphoma: report of a case]. [长期无病生存的肝海绵状血管瘤伴血管内大B细胞淋巴瘤1例报告]。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20241120-00768
J H Yan, S Yao, F Zhang, L Q Luo, S S Lyu, Y H Liu
{"title":"[Long-term disease-free survival hepatic cavernous hemangioma with intravascular large B cell lymphoma: report of a case].","authors":"J H Yan, S Yao, F Zhang, L Q Luo, S S Lyu, Y H Liu","doi":"10.3760/cma.j.cn112151-20241120-00768","DOIUrl":"10.3760/cma.j.cn112151-20241120-00768","url":null,"abstract":"","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"400-402"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Relapse-related candidate genes and their clinicopathological connections of diffuse large B cell lymphoma]. [弥漫性大B细胞淋巴瘤复发相关候选基因及其临床病理联系]。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20240920-00620
Y X Gong, Y F Yang, S N Sun, R M Bai, S S Zhuo, Y Shao, K H Liu, Y Q Shi, Z H Zhang
{"title":"[Relapse-related candidate genes and their clinicopathological connections of diffuse large B cell lymphoma].","authors":"Y X Gong, Y F Yang, S N Sun, R M Bai, S S Zhuo, Y Shao, K H Liu, Y Q Shi, Z H Zhang","doi":"10.3760/cma.j.cn112151-20240920-00620","DOIUrl":"10.3760/cma.j.cn112151-20240920-00620","url":null,"abstract":"<p><p><b>Objective:</b> To explore the relapse-related genes and their clinicopathological connections of diffuse large B cell lymphoma (DLBCL). <b>Methods:</b> Targeted panel sequencing was conducted on 32 eligible DLBCL samples; the patients were diagnosed, treated, and went into complete remission at the First Affiliated Hospital of Nanjing Medical University from January 2015 to December 2019, including 14 cases with recurrence (relapsed group) and 18 cases with long-term complete remission of over five years (remission group). Clinical and pathological data were further reviewed. Fisher's exact test was employed to compare the differences in clinicopathological characteristics and mutation patterns between the two groups. <b>Results:</b> Among the 32 patients, there were 18 males and 14 females, with a male to female ratio of 1.3∶1.0 and a median age of 53 (45.5, 67.0) years. In the relapsed group, PIM1 (11/14), KMT2D (7/14), PRDM1 (6/14), MYD88 (6/14), DTX1 (6/14) emerged as the most frequently mutated genes. In the remission group, while recurrent PIM1, KMT2D and MYD88 mutations were also observed, the TP53 gene exhibited the highest mutation frequency (6/18). Compared to the remission group, relapsed group showed elevated mutation frequencies of PIM1 (<i>P</i>=0.013) and FAT4 (<i>P</i>=0.010), alongside a reduced incidence of TP53 mutations. In all 32 patients, DLBCL with CD79B, CCND3, DTX1, KMT2D and PRDM1 mutations demonstrated a propensity towards advanced clinicopathologic stage. <b>Conclusions:</b> Relapsed DLBCL has distinctive clinicopathological and genetic features. PIM1 and FAT4 may be served as potential biomarkers for screening relapsed DLBCL-NOS and as targets for novel therapeutic strategies.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"348-353"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Values of reticulin fiber staining in evaluation of bone marrow involvement in adult lymphoma]. [网状纤维染色在成人淋巴瘤骨髓受累评价中的价值]。
中华病理学杂志 Pub Date : 2025-04-08 DOI: 10.3760/cma.j.cn112151-20240702-00435
Y J Cao, N N Li, X H Li, S Y Lian, Y Xie, W W Song, Y M Lai, X T Diao, Y F Shi
{"title":"[Values of reticulin fiber staining in evaluation of bone marrow involvement in adult lymphoma].","authors":"Y J Cao, N N Li, X H Li, S Y Lian, Y Xie, W W Song, Y M Lai, X T Diao, Y F Shi","doi":"10.3760/cma.j.cn112151-20240702-00435","DOIUrl":"10.3760/cma.j.cn112151-20240702-00435","url":null,"abstract":"<p><p><b>Objective:</b> To explore the values of reticulin fiber staining (RFS) in evaluating bone marrow (BM) involvement of lymphoma and in grading of BM biopsy from adult lymphoma patients. <b>Methods:</b> Retrospectively,354 cases of adult lymphoma were collected from November 2023 to May 2024 at Peking University Cancer Hospital. BM samples were stained with RFS and immunohistochemical staining (IHC), and flow cytometry (FCM) was also performed with the BM aspirations simultaneously. RFS was graded according to the European Consensus, as high grade (grade 2-3) indicating BM involvement in the study. BM involvement was considered as definite if no less than two positive findings among IHC, FCM, and RFS. Statistical analyses were performed via SPSS software (V23.0). <b>Results:</b> In this series, 52.3% (185/354) of the patients were male; 35.0% (124/354) aged >60 years; BM involvements were found in 34.5% (122/354) cases with high grade of RFS, which, in turn, were lymphoblastic leukemia/lymphoma (ALL/LBL) group (4/4), indolent B-cell lymphoma (IndBCL) group (49.1%, 53/108), transformed B-cell lymphoma (TrBCL) group (2/5), invasive B-cell lymphoma (InvBCL) group (26.5%, 41/155), T and NK cell lymphoma (TNKCL) group (27.3%, 12/44) and classical Hodgkin lymphoma (CHL) group (26.3%, 10/38); if classified by specific types, T-ALL/LBL (2/2), B-ALL/LBL (2/2) and CLL/SLL (8/10) ranked top three. In terms of the positive rate of BM involvement evaluated by RFS, no significant difference was seen between either gender or age groups (<i>χ</i><sup>2</sup>=3.416,<i>P</i>=0.332 and <i>χ</i><sup>2</sup>=4.200,<i>P</i>=0.241); however, significant differences were observed between different lymphoma groups and types (<i>χ</i><sup>2</sup>=29.961,<i>P</i>=0.012 and <i>χ</i><sup>2</sup>=102.546,<i>P</i><0.001, respectively). BM invasion rates indicated by IHC and FCM were 25.4% (90/354) and 13.8% (49/354), respectively. The overall BM invasion rate was 24.3% (86/354), and the sensitivity of RFS, IHC, and FCM was 90.8%, 97.8%, and 55.8%, and specificity was 84.1%, 99.6%, and 98.9%, respectively. Overall, the concordance rate of RFS with IHC and FCM was 83.6% and 74.0%, respectively, including 85.8% and 74.2% for InvBCL group, 79.6% and 75.0% for IndBCL group, 84.1% and 75.0% for TNKCL group, 81.6% and 73.7% for CHL group, 5/5 and 2/5 for TrBCL group, and 4/4 and 3/4 for ALL/LBL group. <b>Conclusions:</b> In the evaluation of BM involvement status of adult lymphoma, high sensitivity and specificity are observed by RFS, and high concordance is also noted with both IHC and FCM. Thus, the BM infiltrating status of adult lymphoma could be evaluated more accurately by a combined usage of the three methods.</p>","PeriodicalId":35997,"journal":{"name":"中华病理学杂志","volume":"54 4","pages":"361-367"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信